prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |review
    Stages in the natural history of lung cancer and
    lead time of screening
In this example, using lung cancer for which clinical trials have demonstrated no efficacy for screening, the principle of lead time is illustrated. Despite person A being diagnosed with disease earlier than person B, they both die at the same time. Thus, no decrease in mortality was gained by person A, only the length of time during which he knew he was sick was increased. Time with disease is extended which leads to the false impression that early detection improves total survival.